Structural Basis of SARS-CoV-2 Polymerase Inhibition by FavipiravirQi Peng, Yi Shi, Ruchao Peng et al.|The Innovation|2021Cited by 86
Structural basis of SARS-CoV-2 polymerase inhibition by FavipiravirQi Peng, Yi Shi, Ruchao Peng et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 50
Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitorsPengfei Wang, Xuebing Li, Babayemi Olawale Oladejo et al.|RSC Advances|2021Cited by 14
Single-Dose Oral Influenza Antiviral Prodrug Enabled by Cholesterol ConjugationChenning Li, Xuebing Li, George F. Gao et al.|Journal of Medicinal Chemistry|2025Cited by 0